GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Float Percentage Of Total Shares Outstanding

Biosergen AB (OSTO:BIOSGN) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Biosergen AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biosergen AB's float shares is 0.00 Mil. Biosergen AB's total shares outstanding is 234.82 Mil. Biosergen AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biosergen AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biosergen AB's Institutional Ownership is 0.03%.

Biosergen AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Biosergen AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/234.82
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosergen AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosergen AB (OSTO:BIOSGN) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
OSTO:BIOVIC B XSAT:DEX OSTO:SPAGO OSTO:SIMRIS B OSTO:ATORX OSTO:NXTCL OSTO:ACOU XSAT:CHOSA OSTO:ONCOZ OSTO:PILA VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Fogdevreten 2, Solna, SWE, 17165
Website
https://www.biosergen.net
Biosergen AB is a biotech company developing innovative antifungal drugs based on latest biopharmaceutical research and development from laboratory facilities in Trondheim, Norway, and several other places worldwide. The company is developing BSG005, a potentially disruptive antifungal drug, which has demonstrated significant safety and potency advantages over competing antifungals.

Biosergen AB Headlines

No Headlines